StanislavTricolici

Life sciences professional building at the intersection of drug safety, biotechnology, and digital innovation.

About

I work at the intersection of pharmacovigilance, regulatory science, and digital innovation. My career spans two European capitals, multiple consulting environments, and ongoing academic research that pushes into computational territory.

With a background in Pharmacy, a Master's in Medical and Pharmaceutical Biotechnology, and an active Erasmus+ research placement focused on fragment-based computational drug design, I bring both operational expertise and a research-driven mindset to everything I do. I have rebuilt pharmacovigilance systems from the ground up, passed regulatory inspections with zero critical findings, and simultaneously founded an educational platform that has reached over 4,000 life science students.

I believe the future of drug safety lies in intelligent, data-driven systems. I am actively building towards that frontier — combining scientific depth with coding skills, machine learning literacy, and a genuine passion for creating tools that matter.

Languages

  • English

    Full professional proficiency

  • German

    Full professional proficiency

  • Romanian

    Native or bilingual proficiency

  • Russian

    Native or bilingual proficiency

  • Ukrainian

    Limited working proficiency

Based in

Prague, Czech Republic

Expertise

01

Pharmacovigilance

End-to-end PV project management, ICSR processing, signal detection, literature monitoring, and GVP compliance across complex multi-vendor environments.

02

Drug Safety & Regulatory

PSMF authorship, SOP development, regulatory submissions, and audit management. Hands-on experience with GVP and GDP inspections.

03

Biotechnology

Advanced studies in medical and pharmaceutical biotechnology, with a focus on drug discovery, development pipelines, and scientific literature analysis.

04

Computational Drug Design

Fragment-based drug design, molecular modeling, and computational approaches applied to early-stage drug discovery. Currently driving Master's thesis research.

05

Scientific Communication

Regulatory documentation, SOP writing, literature synthesis, content creation for life science audiences, and cross-functional stakeholder communication.

06

Digital Innovation

Python, R, SQL, machine learning tools, and AI applications in life sciences. Platform development and technology-driven process improvement.

Work Experience

Research Assistant

Palacký University Olomouc · Olomouc, CZ

Apr 2026 — Present

  • Conducting research in chemoinformatics, computational drug design, and hit identification — applying in silico methodologies to early-stage discovery workflows.
  • Working with molecular modeling, virtual screening, and fragment-based approaches to support the identification and prioritization of novel chemical starting points.

Pharmacovigilance Associate

Pharmexon Consulting s.r.o · Prague, CZ

Aug 2025 — Present

  • Managing independent pharmacovigilance projects as primary client contact, overseeing deliverables and ensuring compliance across complex multi-vendor, centrally-registered product environments.
  • Leading the development and continuous optimization of SOPs, work instructions, and internal PV workflows, raising operational standards across the organization.

Pharmacovigilance & Regulatory Affairs Officer

Karmed HandelsgesmbH · Vienna, AT · Remote

Jun 2024 — Dec 2025

  • Rebuilt the company's pharmacovigilance system from the ground up — authoring critical SOPs, establishing PSMF documentation, and implementing compliant workflows where none had existed.
  • Prepared and submitted regulatory documentation to national authorities, ensuring full alignment with GVP requirements.
  • Led GVP and GDP inspections by AGES (Austrian authority) to successful completion with zero critical findings.
  • Participated in multiple audits as both auditee and auditor, developing deep expertise in audit readiness, deviation management, and documentation standards.

Medical Literature Monitoring Support

Pharmexon Consulting s.r.o · Prague, CZ

Feb 2024 — Jul 2025

  • Conducted systematic literature searches to identify and assess relevant case safety reports for pharmacovigilance purposes across multiple therapeutic areas.
  • Provided direct operational support to Project Managers across day-to-day pharmacovigilance activities, building a comprehensive understanding of the full PV lifecycle.

Pharmacy Intern

Apotheke zum weißen Hirschen · Vienna, AT

Mar 2022 — Oct 2023

  • Gained practical patient-facing experience in medication dispensing, pharmaceutical counselling, and over-the-counter advisory services.
  • Developed a solid clinical foundation in therapeutic classes, drug interactions, medication safety, and pharmacological principles.

Education

Erasmus+ Exchange — Drug Design

Palacký University Olomouc · Olomouc, CZ

Sep 2025 — Jun 2026

Conducting Master's thesis research in fragment-based drug design using computational approaches, molecular modeling, and in silico screening methodologies.

MSc Medical & Pharmaceutical Biotechnology

IMC Krems · Krems, AT

Oct 2024 — Oct 2026

Advanced studies in pharmaceutical biotechnology with emphasis on critical scientific literature analysis, drug discovery methodologies, and development pipeline processes.

BSc Pharmacy

University of Vienna · Vienna, AT

Oct 2020 — Jun 2024

Comprehensive undergraduate training in pharmacology, medicinal chemistry, pharmaceutical technology, and patient safety — providing the scientific foundation for all subsequent professional work.

Skills

Pharmacovigilance & Regulatory

11

ICSR Processing, Signal Detection & Management, Medical Literature Monitoring, PSMF Authorship, SOP Writing, GVP / GDP Compliance, MedDRA Coding, xEVMPD, Regulatory Submissions, Audit Management, GVP Inspection Support

Scientific & Research

08

Computational Drug Design, Fragment-Based Drug Design, Molecular Modeling, Scientific Literature Analysis, Pharmacology, Medicinal Chemistry, Pharmaceutical Biotechnology, PubMed / Scientific Databases

Technical & Digital

10

Python, R, SQL, Bash, Machine Learning, AI Tools, Safety Databases, MS Office Suite, Scientific Regulatory Databases, Platform Development

Communication & Professional

07

Stakeholder Management, Project Management, Client Communication, Process Optimization, Cross-Functional Collaboration, Time Management, Attention to Detail

Projects

01Founder & Platform LeadDec 2021 — Present
wisspo.de

WISSPO.DE

Educational Digital Platform for Life Sciences

Founded and independently built an educational digital platform serving life science students across German-speaking countries. From concept to execution — covering content strategy, platform architecture, user experience, and ongoing technical maintenance.

Certifications

Project Management Foundations

LinkedIn · Mar 2026

AI Fundamentals

DataCamp · Jan 2026

Introduction to Molecular Modeling in Drug Discovery

Schrödinger · Dec 2025

Intermediate SQL

DataCamp · Nov 2025

Good Vigilance Practice Certificate

Semmelweis University · Oct 2025

Visualizing Science with PyMOL 3

Schrödinger · Jul 2025

Pharmacovigilance System Master File (PSMF)

Udemy · Jun 2025

Literature Monitoring in Pharmacovigilance

Udemy · Jan 2025

Signal Detection and Management in Pharmacovigilance

Udemy · Apr 2024

International English Language Testing System (IELTS)

British Council · Mar 2024

Interests

Areas I am actively researching and building towards.

01

AI in Drug Safety

Exploring how large language models and machine learning can transform signal detection, ICSR triage, and pharmacovigilance automation at scale.

02

Computational Drug Discovery

Advancing fragment-based and ML-guided approaches to early-stage drug design — accelerating the path from target to candidate.

03

Digitalization & Automation

Driving the shift from manual, fragmented workflows to connected, automated systems — across industries and functions, enabling organizations to operate faster, smarter, and at scale.

04

Knowledge & Education Platforms

Continuing to invest in platforms that democratize access to life science knowledge and prepare the next generation of researchers and professionals.